Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.
Saved in:
| Title: | Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat. |
|---|---|
| Authors: | Cohn, Danny M.1 (AUTHOR) d.m.cohn@amsterdamumc.nl, Aygören‐Pürsün, Emel2 (AUTHOR), Bernstein, Jonathan A.3 (AUTHOR), Farkas, Henriette4 (AUTHOR), Lumry, William R.5 (AUTHOR), Maurer, Marcus6,7 (AUTHOR), Zanichelli, Andrea8,9 (AUTHOR), Iverson, Matthew10 (AUTHOR), Hao, James10 (AUTHOR), Smith, Michael D.10 (AUTHOR), Yea, Christopher M.11 (AUTHOR), Audhya, Paul K.10 (AUTHOR), Riedl, Marc A.12 (AUTHOR) |
| Source: | Clinical & Translational Allergy. Sep2023, Vol. 13 Issue 9, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457022 |
|---|---|
| DOI: | 10.1002/clt2.12288 |
